title: Meningococcal disease: early recognition is vital to patient outcomes.
abstract: Since the development of vaccines to prevent Haemophilus influenzae type b and Streptococcus pneumoniae, Neisseria meningitidis is the leading cause of bacterial meningitis in the United States. Education of healthcare professionals to improve identification and provide immediate treatment of patients with symptoms consistent with meningococcal disease will result in improved outcomes.
authors.affiliation: UH Neurological Institute, University Hospitals Case Medical Center, Cleveland, Ohio, USA.
authors.forename: Lori
authors.initials: L
authors.lastname: Mertz
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D042241:Early Diagnosis; D006801:Humans; D008585:Meningitis, Meningococcal / Q000175:diagnosis* / Q000188:drug therapy / Q000517:prevention & control; D022401:Meningococcal Vaccines / Q000008:administration & dosage; D009345:Neisseria meningitidis / Q000302:isolation & purification*; D011379:Prognosis; D014481:United States
chemical_list: D000900:Anti-Bacterial Agents; D022401:Meningococcal Vaccines